Document Detail


The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia.
MedLine Citation:
PMID:  12116306     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Hyperglycosylated hCG (HhCG) is the predominant form of chorionic gonadotrophin in states characterized by aggressive trophoblast invasion such as early pregnancy or choriocarcinoma. Pre-eclampsia may be the result of failed or inadequate trophoblast invasion. We investigated whether low levels of maternal urine HhCG levels would predict subsequent pre-eclampsia. STUDY DESIGN: Mid-trimester urine (14-21 weeks) was collected and frozen from non-hypertensive women undergoing genetic amniocentesis. Inclusion criteria were: normal singleton pregnancies without a prior history of pre-eclampsia, hypertension, diabetes or other vascular disorders. The specimens were subsequently thawed, and HhCG levels standardized to urine creatinine were measured. Maternal charts were reviewed after delivery to determine the development of pre-eclampsia. There were a total of 568 study subjects. RESULTS: Pre-eclampsia developed in 26 (4.6%) women. There was a significant correlation between low urine HhCG and subsequent pre-eclampsia (Mantel-Haenszel test of linear association: Chi-square 10.52, p=0.001). The mean HhCG level (ng/mg creatinine) was significantly greater in normals than in those destined to develop pre-eclampsia: 42.7 versus 20.3, p=0.002 (Mann-Whitney U-test). There was a progressive increase in the risk of subsequent pre-eclampsia as HhCG levels fell: HhCG < or =0.9 MoM RR (95% CI)=1.51 (1.15-1.98) compared with < or =0.1 MoM 10.42 (2.0-54.3). CONCLUSION: Low maternal mid-trimester urine HhCG predicted subsequent pre-eclampsia. This appears to support the view that pre-eclampsia results at least in part from poor trophoblast invasion. Thus, HhCG may play a role in trophoblast invasion and measurement of this in urine identifies women at high risk for developing pre-eclampsia.
Authors:
R O Bahado-Singh; A U Oz; J M Kingston; S Shahabi; C D Hsu; L Cole
Related Documents :
8904206 - Pregnancy occurring during complete cytogenetic response after interferon therapy in ch...
20553846 - Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypotherm...
25459796 - Infant characteristics and parental engagement at the transition to parenthood.
14744206 - Relationship between spontaneous kicking and age of walking attainment in preterm infan...
19491116 - Deprivation and dysphagia in premature infants.
18034166 - False-positive results on colorimetric carbon dioxide analysis in neonatal resuscitatio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  22     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-07-12     Completed Date:  2002-12-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  478-81     Citation Subset:  IM    
Copyright Information:
Copyright 2002 John Wiley & Sons, Ltd.
Affiliation:
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06520, USA. Ray.Bahado-Singh@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniocentesis
Chorionic Gonadotropin / urine*
Female
Gestational Age
Humans
Logistic Models
Pre-Eclampsia / urine*
Pregnancy
Risk
Risk Factors
Trophoblasts / physiology*
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/glycosylated HCG

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pallister-Killian syndrome: difficulties of prenatal diagnosis.
Next Document:  An increase in cost-effectiveness of first trimester maternal screening programmes for fetal chromos...